Patented in 1998 (expired 2018), BPC-157 is also referred to as PL 14736, PL-10, or Bepecin in the scientific literature [3, 4, 5]
FitzGerald MP and Kotarinos R: Rehabilitation of the short pelvic floor
Why the Combination Works The molecular synergy between these peptides creates effects exceeding what either achieves alone
The compounds discussed are investigational and, unless otherwise noted, have not been approved for human therapeutic use by Health Canada or any other regulatory body
At Blue Skies Health & Wellness, peptide therapy discussions are grounded in current evidence, patient safety, and individualized care to ensure that any intervention aligns with your health needs and long-term well-being.